Mark Lunt

Manchester Academic Health Science Centre — United Kingdom

Medicine · Health Sciences

88h-index23.9kcitations636works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(218), Systemic Lupus Erythematosus Research(116), Autoimmune and Inflammatory Disorders Research(73), Psoriasis: Treatment and Pathogenesis(48), Bone health and osteoporosis research(46)

Publications618 total

102 A cohort study on recurrent serious infection risk with systemic treatments for psoriasis
Journal of Investigative Dermatology·2025
Serious Infection Risk with Systemic Treatments for Psoriasis: A Systematic Review and Network Meta-analysis Combining Randomised and Non-randomised Evidence
Dermatology and Therapy·2025Open Access
Describing variability of intensively collected longitudinal ordinal data with latent spline models
Scientific Reports·2025Open Access
Improving disease misclassification and prevalence estimates by linking primary and secondary care electronic health records: an illustration from arthritis research
American Journal of Epidemiology·2025· 1 citedOpen Access
O07 Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
British Journal of Dermatology·2025Open Access
Comparative risk of severe constipation in patients treated with opioids for non-cancer pain: a retrospective cohort study in Northwest England
BMC Medicine·2025· 5 citedOpen Access
POS1035 COMPARATIVE RISK OF DELIRIUM AMONG OPIOID USERS FOR NON-CANCER PAIN: A LARGE-SCALE RETROSPECTIVE COHORT STUDY
Annals of the Rheumatic Diseases·2025Open Access
POS0212 MACHINE LEARNING MODELS FOR PREDICTING OPIOID-RELATED HOSPITALISATION IN NEW OPIOID USERS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES
Annals of the Rheumatic Diseases·2025Open Access
Evaluating changes in baseline characteristics and drug-utilization pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) cohort
Clinical and Experimental Dermatology·2025· 2 citedOpen Access
OA06 Machine learning models for predicting opioid-related hospitalisation in new opioid users with rheumatic and musculoskeletal diseases
Lara D. Veeken·2025Open Access
Effectiveness of Adalimumab Biosimilars and Originator for Psoriasis
JAMA Dermatology·2025· 4 citedOpen Access
Switching back to originator adalimumab from biosimilars in psoriasis: A cohort study from <scp>BADBIR</scp>
Journal of the European Academy of Dermatology and Venereology·2025Open Access
The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohort
British Journal of Dermatology·2025
Describing variability of intensively collected longitudinal ordinal data with latent spline models
2025Open Access
Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study
British Journal of Dermatology·2024· 3 citedOpen Access
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK–Irish A-STAR register
British Journal of Dermatology·2024· 10 citedOpen Access
O02 The effectiveness of adalimumab biosimilars and originator for the treatment of psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
British Journal of Dermatology·2024Open Access
O03 Comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic eczema: results from the UK-Irish A-STAR register
British Journal of Dermatology·2024· 2 citedOpen Access
POS0390 POTENTIAL IMPACT OF EMA RISK MINIMISATION MEASURES WITH JAKi ON CURRENT JAKi PRESCRIBING IN UK
Annals of the Rheumatic Diseases·2024
POS0294 RISK FACTORS FOR OPIOID-RELATED HOSPITAL ADMISSIONS IN RHEUMATIC AND MUSCULOSKELETAL DISEASE PATIENTS NEWLY INITIATED ON OPIOIDS: A RETROSPECTIVE COHORT STUDY
Annals of the Rheumatic Diseases·2024
page 1 of 31Next →

Frequent Co-authors

Deborah Symmons(24), Kimme L Hyrich(18), Alan J. Silman(16), William G Dixon(13), Kath Watson(13), J. Reeve(10), Terence W O’Neill(8), Dieter Felsenberg(8), Louise Mercer(7), Jorge B. Cannata‐Andía(7), P. Masaryk(7), Cyrus Cooper(6), L I Benevolenskaya(6), Huibert A. P. Pols(6), Christa Scheidt‐Nave(6), K. Weber(6), James Galloway(5), Anthony D. Woolf(5), J. Dequeker(5), John А. Kanis(5)